CAPPS KATHLEEN S. (See Remarks) sold 2.3% of their position (207.00 shares) of ENANTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $2.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2025ACC: 0002064832-25-000053
Officer· See Remarks
Since Aug 2025
-292.00
Net shares
Net seller
$4.1K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
292.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−85.00
Price / share
$14.12
Trade value
$1.20K
% of position
0.9%
12/1/2025
8.99K→8.91K
Common Stock
Direct
Shares
−207.00
Price / share
$13.96
Trade value
$2.89K
% of position
2.3%
12/2/2025
8.91K→8.70K
Total
Net shares
−292.00
Net value
-$4.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | F · Tax Withholding | −85.00 | $14.12 | $1.20K | 0.9% | 8.99K | 8.91K |
| Common Stock Direct | 12/2/2025 | S · Sale | −207.00 | $13.96 | $2.89K | 2.3% | 8.91K | 8.70K |
| Total | −292.00 | -$4.09K | ||||||
Derivative Transactions0
No derivative transactions reported